Sanjiv.Parant.

{
  "main_header": {
    "sid": 328426,
    "name": "Sanjiv.Parant.",
    "stock_name": "Sanjiv.Parant.",
    "full_name": "Sanjivani Paranteral Ltd",
    "name_url": "stocks-analysis/sanjivparant",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "188.85",
    "chg": 0.9,
    "chgp": "0.48%",
    "dir": 1,
    "prev_price": "187.95",
    "mcapval": "242.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531569,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE860D01013",
    "curr_date": "Aug 11, 12:32 PM",
    "curr_time": "12:56 PM",
    "last_traded_at": "Aug 11, 12:32 PM IST",
    "bse_nse_vol": "619 ",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanjivani Paranteral Ltd Gains 18.82%: 2 Key Factors Driving the Volatile Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-gains-1882-2-key-factors-driving-the-volatile-week-4143861",
        "imagepath": "",
        "date": "2026-08-09 09:01:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> Stock opens strong at Rs.164.85 (+1.38%)</p>\n                    <p><strong>4 Aug:</strong> Sharp decline to Rs.159.60 (-3.18%) amid cautious trading</p>\n                    <p><strong>5 Aug:</strong> Explosive rally to Rs.191.50 (+19.99%) on heavy volume</p>\n                    <p><strong>6 Aug:</strong> Mojo Grade downgraded to Strong Sell; price rises further to Rs.202.60 (+5.80%)</p>\n                    <p><strong>7 Aug:</strong> Profit-taking leads to Rs.193.20 close (-4.64%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.162.60</di..."
      },
      {
        "title": "Sanjivani Paranteral Ltd Downgraded to Strong Sell Amid Valuation and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-downgraded-to-strong-sell-amid-valuation-and-financial-concerns-4139131",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanjivaniParant_mojoScore_4139131.png",
        "date": "2026-08-06 08:02:40",
        "description": "Sanjivani Paranteral Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 5 August 2026, driven primarily by a shift to an expensive valuation profile, deteriorating financial trends, and weakening technical indicators. Despite a strong long-term growth record, recent quarterly results and market performance have raised concerns among investors and analysts alike."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Price Attractiveness Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-price-attractiveness-decline-4139005",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanjivaniParant_valuationdot_4139005.png",
        "date": "2026-08-06 08:00:33",
        "description": "Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, raising questions about its price attractiveness amid a volatile market backdrop. Despite a recent surge in share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical and peer averages suggest caution for investors."
      },
      {
        "title": "Sanjivani Paranteral Ltd Gains 9.38%: 3 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-gains-938-3-key-factors-driving-the-weeks-volatility-4132137",
        "imagepath": "",
        "date": "2026-08-02 09:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens at Rs.150.20, modest gain of 1.04%</p>\n                    <p><strong>28 Jul:</strong> Downgrade to Strong Sell announced; stock surges 13.65% to Rs.170.70</p>\n                    <p><strong>29 Jul:</strong> Valuation concerns highlighted; stock declines 2.93% to Rs.165.70</p>\n                    <p><strong>30 Jul:</strong> Upgrade to Sell rating; stock falls 3.05% to Rs.160.65</p>\n                    <p><strong>31 Jul:</strong> Week closes with a 1.21% gain at Rs.162.60</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.150.20<..."
      },
      {
        "title": "Sanjivani Paranteral Ltd Upgraded to Sell on Improved Valuation and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-upgraded-to-sell-on-improved-valuation-and-financial-metrics-4127904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SanjivaniParant_mojoScore_4127904.png",
        "date": "2026-07-30 08:01:53",
        "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 29 July 2026. This revision reflects a notable improvement in valuation metrics alongside a mixed financial trend and technical outlook. Despite recent quarterly setbacks, the company’s fair valuation and operational efficiency have prompted a more favourable stance from analysts."
      },
      {
        "title": "Sanjivani Paranteral Ltd Downgraded to Strong Sell Amid Valuation and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-downgraded-to-strong-sell-amid-valuation-and-financial-concerns-4125112",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SanjivaniParant_mojoScore_4125112.png",
        "date": "2026-07-29 08:02:31",
        "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 28 July 2026. This revision reflects a combination of deteriorating financial trends, expensive valuation metrics, weakening technical indicators, and a reassessment of the company’s overall quality. The downgrade comes despite a recent sharp rally in the stock price, which surged 13.65% on the day following the announcement."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Price Attractiveness Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-price-attractiveness-challenges-4124951",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SanjivaniParant_valuationdot_4124951.png",
        "date": "2026-07-29 08:00:32",
        "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, prompting a downgrade in its Mojo Grade to Strong Sell. Despite a recent surge in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have moved into expensive territory, raising questions about its price attractiveness relative to historical and peer benchmarks."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-4121004",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SanjivaniParant_mojoScore_4121004.png",
        "date": "2026-07-26 10:10:40",
        "description": "Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Sanjivani Paranteral Ltd Rating Upgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-rating-upgraded-to-sell-amid-mixed-financial-and-technical-signals-4103020",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SanjivaniParant_mojoScore_4103020.png",
        "date": "2026-07-15 08:01:41",
        "description": "Sanjivani Paranteral Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite ongoing financial challenges. The revision follows a detailed reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals, highlighting both the company’s strengths and areas of concern within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 250,
    "sid": "328426",
    "stock_news_url": "https://www.marketsmojo.com/news/sanjivani-paranteral-328426"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-Jul-2026",
      "details": "News Paper Advertisment of Postal Ballot Notice of Sanjivani Paranteral Limited pursuant to regulation 47 of Securities and Exchange Board of India (Listing Obligation and Disclosures requiredment) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "23-Jul-2026",
      "details": "Notice of Postal ballot dated 23rd July 2026 of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Preferential Issue",
      "datetime": "23-Jul-2026",
      "details": "As per Attachment",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sanjivani Paranteral Ltd Gains 18.82%: 2 Key Factors Driving the Volatile Week

2026-08-09 09:01:54

Key Events This Week

3 Aug: Stock opens strong at Rs.164.85 (+1.38%)

4 Aug: Sharp decline to Rs.159.60 (-3.18%) amid cautious trading

5 Aug: Explosive rally to Rs.191.50 (+19.99%) on heavy volume

6 Aug: Mojo Grade downgraded to Strong Sell; price rises further to Rs.202.60 (+5.80%)

7 Aug: Profit-taking leads to Rs.193.20 close (-4.64%)

Week Open

Rs.162.60Read full news article

Sanjivani Paranteral Ltd Downgraded to Strong Sell Amid Valuation and Financial Concerns

2026-08-06 08:02:40

Sanjivani Paranteral Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 5 August 2026, driven primarily by a shift to an expensive valuation profile, deteriorating financial trends, and weakening technical indicators. Despite a strong long-term growth record, recent quarterly results and market performance have raised concerns among investors and analysts alike.

Read full news article

Sanjivani Paranteral Ltd Valuation Shifts Signal Price Attractiveness Decline

2026-08-06 08:00:33

Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, raising questions about its price attractiveness amid a volatile market backdrop. Despite a recent surge in share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical and peer averages suggest caution for investors.

Read full news article

Sanjivani Paranteral Ltd Gains 9.38%: 3 Key Factors Driving the Week’s Volatility

2026-08-02 09:00:07

Key Events This Week

27 Jul: Stock opens at Rs.150.20, modest gain of 1.04%

28 Jul: Downgrade to Strong Sell announced; stock surges 13.65% to Rs.170.70

29 Jul: Valuation concerns highlighted; stock declines 2.93% to Rs.165.70

30 Jul: Upgrade to Sell rating; stock falls 3.05% to Rs.160.65

31 Jul: Week closes with a 1.21% gain at Rs.162.60

Week Open

Rs.150.20<...

Read full news article

Sanjivani Paranteral Ltd Upgraded to Sell on Improved Valuation and Financial Metrics

2026-07-30 08:01:53

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 29 July 2026. This revision reflects a notable improvement in valuation metrics alongside a mixed financial trend and technical outlook. Despite recent quarterly setbacks, the company’s fair valuation and operational efficiency have prompted a more favourable stance from analysts.

Read full news article

Sanjivani Paranteral Ltd Downgraded to Strong Sell Amid Valuation and Financial Concerns

2026-07-29 08:02:31

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 28 July 2026. This revision reflects a combination of deteriorating financial trends, expensive valuation metrics, weakening technical indicators, and a reassessment of the company’s overall quality. The downgrade comes despite a recent sharp rally in the stock price, which surged 13.65% on the day following the announcement.

Read full news article

Sanjivani Paranteral Ltd Valuation Shifts Signal Price Attractiveness Challenges

2026-07-29 08:00:32

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, prompting a downgrade in its Mojo Grade to Strong Sell. Despite a recent surge in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have moved into expensive territory, raising questions about its price attractiveness relative to historical and peer benchmarks.

Read full news article

Sanjivani Paranteral Ltd is Rated Sell

2026-07-26 10:10:40

Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Sanjivani Paranteral Ltd Rating Upgraded to Sell Amid Mixed Financial and Technical Signals

2026-07-15 08:01:41

Sanjivani Paranteral Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite ongoing financial challenges. The revision follows a detailed reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals, highlighting both the company’s strengths and areas of concern within the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News